Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Insights into the HIV Latency and the Role of Cytokines.

Hokello J, Sharma AL, Dimri M, Tyagi M.

Pathogens. 2019 Sep 4;8(3). pii: E137. doi: 10.3390/pathogens8030137. Review.

2.

Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.

Gergely JE, Dorsey AE, Dimri GP, Dimri M.

Mol Carcinog. 2018 Jul;57(7):831-841. doi: 10.1002/mc.22804. Epub 2018 Mar 25.

3.

A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.

Dimri M, Kang M, Dimri GP.

Oncotarget. 2016 Jun 14;7(24):36220-36234. doi: 10.18632/oncotarget.8811.

4.

MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.

Cho JH, Dimri M, Dimri GP.

J Biol Chem. 2015 Apr 17;290(16):10555-67. doi: 10.1074/jbc.M114.624361. Epub 2015 Mar 3.

5.

PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.

Dimri M, Cho JH, Kang M, Dimri GP.

J Biol Chem. 2015 Jan 30;290(5):3033-44. doi: 10.1074/jbc.M114.615179. Epub 2014 Dec 12.

6.

microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts.

Dimri M, Carroll JD, Cho JH, Dimri GP.

Cell Cycle. 2013 Nov 15;12(22):3537-46. doi: 10.4161/cc.26592. Epub 2013 Sep 24.

7.

A comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cells.

Helikar T, Kochi N, Kowal B, Dimri M, Naramura M, Raja SM, Band V, Band H, Rogers JA.

PLoS One. 2013 Apr 18;8(4):e61757. doi: 10.1371/journal.pone.0061757. Print 2013.

8.

A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway.

Cho JH, Dimri M, Dimri GP.

J Biol Chem. 2013 Feb 1;288(5):3406-18. doi: 10.1074/jbc.M112.422931. Epub 2012 Dec 13.

9.

Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer.

Ortega-Cava CF, Raja SM, Laiq Z, Bailey TA, Luan H, Mohapatra B, Williams SH, Ericsson AC, Goswami R, Dimri M, Duan L, Band V, Naramura M, Band H.

J Carcinog. 2011;10:29. doi: 10.4103/1477-3163.90443. Epub 2011 Nov 30.

10.

╬▓TrCP regulates BMI1 protein turnover via ubiquitination and degradation.

Sahasrabuddhe AA, Dimri M, Bommi PV, Dimri GP.

Cell Cycle. 2011 Apr 15;10(8):1322-30. Epub 2011 Apr 15.

11.

Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration.

Duan L, Raja SM, Chen G, Virmani S, Williams SH, Clubb RJ, Mukhopadhyay C, Rainey MA, Ying G, Dimri M, Chen J, Reddi AL, Naramura M, Band V, Band H.

J Biol Chem. 2011 Jan 7;286(1):620-33. doi: 10.1074/jbc.M110.188086. Epub 2010 Oct 12.

12.

Endosomal-sorting complexes required for transport (ESCRT) pathway-dependent endosomal traffic regulates the localization of active Src at focal adhesions.

Tu C, Ortega-Cava CF, Winograd P, Stanton MJ, Reddi AL, Dodge I, Arya R, Dimri M, Clubb RJ, Naramura M, Wagner KU, Band V, Band H.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16107-12. doi: 10.1073/pnas.1009471107. Epub 2010 Aug 30.

13.

Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain.

Yadav AK, Sahasrabuddhe AA, Dimri M, Bommi PV, Sainger R, Dimri GP.

Mol Cancer. 2010 Jun 22;9:158. doi: 10.1186/1476-4598-9-158.

14.

The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.

Bommi PV, Dimri M, Sahasrabuddhe AA, Khandekar J, Dimri GP.

Cell Cycle. 2010 Jul 1;9(13):2663-73.

15.

Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.

Dimri M, Bommi PV, Sahasrabuddhe AA, Khandekar JD, Dimri GP.

Carcinogenesis. 2010 Mar;31(3):489-95. doi: 10.1093/carcin/bgp305. Epub 2009 Dec 7.

16.

Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture.

Duan L, Chen G, Virmani S, Ying G, Raja SM, Chung BM, Rainey MA, Dimri M, Ortega-Cava CF, Zhao X, Clubb RJ, Tu C, Reddi AL, Naramura M, Band V, Band H.

J Biol Chem. 2010 Jan 8;285(2):1555-68. doi: 10.1074/jbc.M109.057976. Epub 2009 Oct 13.

17.

A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells.

Raja SM, Clubb RJ, Bhattacharyya M, Dimri M, Cheng H, Pan W, Ortega-Cava C, Lakku-Reddi A, Naramura M, Band V, Band H.

Cancer Biol Ther. 2008 Oct;7(10):1630-40. Epub 2008 Oct 9.

18.

Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation.

Germaniuk-Kurowska A, Nag A, Zhao X, Dimri M, Band H, Band V.

Cancer Res. 2007 Dec 15;67(24):11789-97. Erratum in: Cancer Res. 2008 Mar 1;68(5):1609.

19.

Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.

Datta S, Hoenerhoff MJ, Bommi P, Sainger R, Guo WJ, Dimri M, Band H, Band V, Green JE, Dimri GP.

Cancer Res. 2007 Nov 1;67(21):10286-95.

20.

Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.

Reddi AL, Ying G, Duan L, Chen G, Dimri M, Douillard P, Druker BJ, Naramura M, Band V, Band H.

J Biol Chem. 2007 Oct 5;282(40):29336-47. Epub 2007 Jul 9.

Supplemental Content

Loading ...
Support Center